To be or not to beI’m not sure yet if they’re shaking retail out or if indeed they’re gonna bring it down a bit more before the move.
MRNA trade ideas
Earnings watch 8/3/23 pre-marketEarnings watch 8/3/23 pre-market:
Here's a quarterly view 24hr ext comparison chart with the tickerTracker MFI Oscillator.
SHAK
EXPE
CI
HAS
COP
PZZA
CARS
WBD
BUD
MRNA
MRNA earnings setupMRNA earnings are on Thursday 8/3 pre-market. July 26 (Reuters) - Moderna (MRNA.O) and its partner Merck (MRK.N) said on Wednesday that they had begun enrolling patients in a late-stage study testing their personalized mRNA-based skin cancer vaccine in combination with the immunotherapy Keytruda. Data from a mid-stage study in 157 patients had shown that the vaccine combination cut the risk of recurrence or death by 44% in patients with melanoma, the most deadly form of skin cancer, when compared with Keytruda alone.
I'm posting this as a long for MRNA because of the technical entry setup heading into earnings on Thursday. MRNA future earnings guidance should be much better than the bad earnings results for Q2 2023. Technically speaking, 115 is a very good place to start a MRNA dca share or far dated expiry calls long position. 145 is MRNA anchored VWAP for 2023, so that is my upside target area for 2023.
Q2 June 2023 Consensus:
EPS: -3.84
Revenue: 319.64 M
MRNA options data:
8/18/23 expiry
Put Volume Total 118
Call Volume Total 306
Put/Call Volume Ratio 0.39
Put Open Interest Total 13,153
Call Open Interest Total 16,143
Put/Call Open Interest Ratio 0.81
1/19/2024 LEAPS
Put Volume Total 54
Call Volume Total 109
Put/Call Volume Ratio 0.50
Put Open Interest Total 56,492
Call Open Interest Total 64,044
Put/Call Open Interest Ratio 0.88
Triple-Bottom on ModernaTriple bottom is developing. If Moderna can beat on Earnings and have a good forward outlook, it can bounce from here to never see this bottom again.
maybe it works maybe it doesntbut worth the dice roll IMO.
the coin flip.
the hand
May the odds be with you.
MRNA a medical Technology Stock LONG MRNA is a medical technology company. It is in the vaccine sector and competes ( well) with
NVAX and PFE among others. Earnings are upcoming on 8/3 in about a week.
On the 30 minute chart it appears to be in a descending wedge pattern which is typically
a bottoming with a breakout over and beyond the descending trendline. The relative
trend indicator shows the downtrend to be a slow grinding type trend with some minor
corrections along the way. As might be expected the RS lines are low in the indicator's
channel. I see this as a setup for a pre-earnings play with the expectation that MRNA
could breakout above the resistance trend line and move toward the horizontal resistance
of the triple top earlier in mid-July. I see medical stocks as a good alternative to technology
stocks that may be overextended and stressed by the current financial chaos pressuring
the markets. Another approach is a two call options targeting $ 125 expiring 8/11
and running the first until 100% profit or 8/2, the day before the expiration whichever
comes first and letting the other run through earnings into the middle of the following
week at 8/9. I always like to cut these short of expiration by a few days to diminish the
effects of time decay.
Moderna MRNA is Showing a ClueModerna MRNA is Showing a potential Clue based on the RSI 1 Week chart.
Med Stocks are currently over-sold, thereby offering Long Term Investors a potential entry point.
Your thoughts - ideas and comments are appreciated.
Enjoy.
Kind Regards Graham Hitchcox.
Puts tradeBought puts. Is a little risky bc it can break up. But I like this stock options, are very liquid and there are not expensive.
$MRNA - Possible ReversalNASDAQ:MRNA Is basing inside descending broadening wedge and starting to break out.
Both RSI and MACD is displaying bullish divergence. $126 - $127 is POC resistance and breaking above that area will be bullish.
Notice that the stock is in Stage 1 bottoming process. So it has a lot of room to run. I will be building a position in the coming week.
Targets - $160, $180, $210
Risk - $100, $60
If you like this tweet, don't forget to follow, like and retweet.
MRNA // Falling Wedge at DailyHello Folks,
We can see Falling Wedge pattern clearly at MRNA with RSI positive divergence.
I consider it important that this image is formed at a significant level of horizontal support.
As a condition to enter the position, it would be reasonable to wait for the formation of a new high.
Puts idea, I hope this one plays outPrice is hitting an important area of resistance and Nasdaq also is touching a major resistance. I bought some puts:
Strike 128
Exp: 06/26
Downtrend Continuation for $MRNA :-)The hype of elixir ability of mRNA vaccines by Moderna has reached a peak in Aug 2021
Price reached as high as 500 dollar.
But it turns negative after that.
after a massive plunge, price has been consolidating between 118 - 208 for more than 1.5 years, it looks like price has been hovering around 118 to go lower.
If the downtrend continues after the consolidation, chances are high that in the next 1.5 years or so, price will fall back between 50 - 80
I am prone towards more downside, although i could be wrong
This is just my own research and should never be construed as buy or sell call
MRNA coming to China ? Read this news here
If both countries could find a way to partner each other , would this not accelerate the pace of their zero Covid policy ? Watching this news closely........
MRNA TO THE MOONNASDAQ:MRNA looking to absolutely blast off here. It has had a clean 5 waves down and it's about time for a bounce. Falling Wedge + Divergence = Moon.
Let's keep it simple. Buy now. Sell at 160 by EOY.
MRNA at it's most important levelModerna is testing arguably it's most important level, where we found more price interaction. The price has been compressing and now we can expect an important movement in the short term.
What would it be?
$MRMA 2024 Will bring a bad flu season ... good for health stock2024 Is going to bring some challenges during flu season. Best to buy in now when stocks are low..... and sell high later on... Enjoy
Could be a nice set up for a short Hopefully this dies ... And doesnt wake up ever again.
Or someone can call another pandemic and then vaccines are about to be taken again right? say 2025?
MODERNA $305 | Bidding at $220 and $150 Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
for now Watch or Chrun at key leves (eyeball the box)
May Gainers (MRNA, account up 0.25%)10th trade in May is NASDAQ:MRNA .
Holding period is 22 days (5/1/23 - 5/23/23).
Account is up 0.25%.
Total return in May is 3.83%.
Profits Over Patients: The Morally Complex Realm of Big PharmaThis strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price manipulation is a notorious strategy where companies arbitrarily hike drug prices, often without any significant improvements in their efficacy.
"Big Pharma" has faced backlash for allegedly contributing to the opioid crisis . By aggressively marketing highly addictive pain medications , they may have exacerbated a public health catastrophe, leading to thousands of deaths annually.
Such practices illuminate the immoral landscape of the pharmaceutical industry. While these firms play a vital role in global healthcare, their business tactics often prioritize profits over patients, demanding a closer scrutiny of this sector's ethics.
1. Johnson & Johnson (JNJ): Around $440 billion
2. Pfizer Inc. (PFE): Around $240 billion
3. Moderna Inc. (MRNA): Around $110 billion
4. Merck & Co., Inc. (MRK): Around $200 billion
TOTAL = 1 Trillion
Good context for short selling ?support zone become resistance zone also context is looking good for short selling
price is below weekly and monthly VWAP
m30 chart show bearish engulfing to confirm entry
so this level is OK to short
